4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cumberland Pharmaceuticals Inc. (CPIX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Nashville, United States with about 93 employees. Its market capitalization is roughly $117 million. In the fiscal year ended 2025-12-31, CPIX reported $44M in revenue and ($3M) in net income.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.
Interactive charts & full statements → Open the CPIX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $44M | $38M | $40M | $42M | — |
| Gross Profit | $38M | $31M | $34M | $33M | — |
| Operating Income (EBIT) | ($3M) | ($6M) | ($10M) | ($6M) | — |
| Net Income | ($3M) | ($6M) | ($6M) | ($6M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $9M | $14M | $8M | $11M | $12M | — |
| Gross Profit | $7M | $11M | $7M | $9M | $10M | — |
| Operating Income (EBIT) | ($3M) | ($1M) | ($2M) | ($1M) | $1M | — |
| Net Income | ($3M) | ($1M) | ($2M) | ($1M) | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $77M | $76M | $82M | $93M | — |
| Total Liabilities | $52M | $53M | $52M | $57M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CPIX viewer.
About TickerBase · Data methodology & sources